Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-014906

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mark W Hahn
Officer — EVP and CFO
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F1$3.15Feb 23, 2017A25,000A—Feb 22, 2027Common Stock25,00025,000D
Restricted Stock UnitsF2,F3—Feb 23, 2017A25,000A——Common Stock25,00025,000D
Employee Stock Option (Right to Buy)F4$23.51holding————Dec 31, 2024Common Stock46,36346,363D
Employee Stock Option (Right to Buy)F5$2.09holding————Feb 1, 2020Common Stock46,89046,890D
Employee Stock Option (Right to Buy)F6$2.09holding————Jul 28, 2020Common Stock7,6437,643D
Employee Stock Option (Right to Buy)F7$2.09holding————Dec 7, 2020Common Stock9,0749,074D
Employee Stock Option (Right to Buy)F8$7.62holding————Mar 19, 2022Common Stock25,00025,000D
Employee Stock Option (Right to Buy)F9$6.63holding————Jan 17, 2023Common Stock50,00050,000D
Employee Stock Option (Right to Buy)F10$13.10holding————Jan 7, 2024Common Stock15,00015,000D
Employee Stock Option (Right to Buy)F11$13.10holding————Jan 7, 2024Common Stock45,00045,000D
Employee Stock Option (Right to Buy)F12$31.13holding————Dec 31, 2025Common Stock59,66059,660D
Employee Stock Option (Right to Buy)F13$3.00holding————Jan 2, 2027Common Stock125,000125,000D
Restricted Stock UnitsF2,F3—holding—————Common Stock50,00050,000D

Explanation of responses